Načítá se...
Accessibility to Oral Antiviral Therapy for Patients with Chronic Hepatitis C in the United States
Background: Hepatitis C (HCV) direct acting antiviral agents (DAAs) are safe, effective, and tolerable. Most contraindications to interferon-based treatment are no long applicable. The aims of this study were to understand the predictors of approval to drug accessibility. Methods: We studied all con...
Uloženo v:
| Vydáno v: | J Clin Transl Hepatol |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
XIA & HE Publishing Inc.
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4913077/ https://ncbi.nlm.nih.gov/pubmed/27350937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14218/JCTH.2016.00011 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|